The muscle atrophic phenotype of MuSK myasthenia gravis: Insights from a preclinical rat model

Using a rat model of MuSK myasthenia gravis, this study reveals that MuSK autoimmunity drives selective atrophy of slow-twitch muscle fibers through profound proteome remodeling characterized by disrupted mitochondrial and translational homeostasis, extending beyond mere neuromuscular junction impairment.

The Gist

Imagine your body is a massive, high-tech construction site. The muscles are the workers, and the neuromuscular junction (NMJ) is the specific radio tower where the brain sends orders to the workers to start moving.

In a healthy person, there's a foreman named MuSK (Muscle-Specific Kinase) standing at that radio tower. His job is to make sure the radio antennas (receptors) are built strong and stay connected so the workers get clear instructions.

The Problem: The "Glitch" in the System

This paper studies a specific type of muscle disease called MuSK Myasthenia Gravis (MG). In this condition, the body's immune system gets confused. Instead of fighting a virus, it creates "rogue security guards" (antibodies) that attack the MuSK foreman.

When MuSK is attacked, the radio tower breaks down. The workers (muscle fibers) stop getting clear orders, leading to weakness and fatigue. But this paper discovered something new: It's not just about broken radios; the workers themselves are starting to shrink and lose their tools.

The Experiment: A Rat Model

The researchers couldn't experiment on humans, so they built a "simulation" using rats.

• The Setup: They injected the rats with a piece of the MuSK protein to trick their immune systems into attacking it, just like in human patients.
• The Result: The rats developed the disease. They lost weight, their muscles got weak, and their "radio towers" (NMJs) became fragmented and disconnected.

The Big Discovery: Not All Muscles Are Equal

Here is where the story gets interesting. The researchers looked at three different types of muscles in the rats:

1. The Soleus (The Marathon Runner): A slow-twitch muscle in the calf used for standing and walking.
2. The Diaphragm (The Breather): The muscle that helps you breathe.
3. The Sternohyoideus (The Neck Muscle): A fast-twitch muscle used for quick movements.

The Finding: The disease didn't hit everyone equally.

• The Marathon Runner (Soleus) was devastated. It shrank significantly. It was like a marathon runner who suddenly lost their shoes, their energy bars, and their training plan all at once.
• The Breather (Diaphragm) was confused but fighting back. It had some damage, but it tried to compensate by building more tools to fix itself.
• The Neck Muscle was mostly fine. It barely noticed the attack.

The Analogy: Imagine a storm hitting a city. The slow, steady neighborhoods (slow-twitch muscles) were flooded and destroyed. The busy commercial district (fast-twitch muscles) had some damage but managed to stay standing. The storm didn't hit the suburbs at all.

The "Why": A Double Whammy

The paper explains that the muscle wasting happens for two reasons:

1. The "Use It or Lose It" Effect: Because the radio tower is broken, the muscle doesn't get used properly, so it starts to wither.
2. The "Internal Sabotage": This is the new discovery. Even if you ignore the broken radio, the MuSK attack seems to trigger a "self-destruct" switch inside the muscle cells, specifically in the slow-twitch ones.

What's happening inside the cell?

• The Power Plant is Failing: The mitochondria (the cell's battery) are breaking down. The muscle is running out of energy.
• The Factory is Shutting Down: The ribosomes (the machines that build muscle proteins) are being dismantled. The muscle can't repair itself.
• The Trash Crew is Overactive: The cell starts eating its own parts (a process called proteolysis) because it thinks it's in danger.

The Takeaway

This study is like a detective story that solved a mystery. For a long time, doctors thought MuSK-MG was just a problem with the connection between the nerve and the muscle.

This paper says: "No, it's much deeper."

The attack on MuSK doesn't just disconnect the nerve; it fundamentally changes the biology of the muscle cells, especially the slow-twitch ones that keep us standing and moving. It turns the muscle's internal power plants off and tells the factory to stop building.

Why does this matter?
If we only treat the "broken radio" (the nerve connection), we might not fix the "shrinking worker" (the muscle atrophy). This research suggests that future treatments for MuSK-MG patients might need to include therapies that protect the muscle's internal power plants and stop the self-destruction, not just fix the nerve signal. It's about saving the worker, not just fixing the radio.

Technical Summary

1. Problem Statement

Myasthenia Gravis (MG) is an autoimmune disorder characterized by neuromuscular junction (NMJ) disruption. While the AChR-MG subtype is well-studied, the MuSK-MG subtype (caused by antibodies against Muscle-Specific Kinase) presents distinct clinical features, notably selective muscle atrophy (particularly in tongue, facial, and bulbar muscles) alongside weakness.

• Knowledge Gap: While the role of MuSK in NMJ formation (via the Agrin-LRP4-MuSK pathway) is established, the intrinsic myocellular mechanisms driving the specific atrophy seen in MuSK-MG remain unclear. It is unknown whether atrophy is solely a consequence of disuse due to NMJ failure or if MuSK dysfunction triggers direct intracellular signaling pathways regulating muscle mass (e.g., via TGF-β/BMP signaling).
• Objective: To characterize the molecular and morphological phenotype of skeletal muscle in MuSK-MG using a preclinical rat model, specifically investigating fiber-type selectivity, NMJ integrity, and whole-muscle proteome remodeling.

2. Methodology

The study employed a cross-sectional design using an active immunization rat model to induce MuSK-MG.

• Animal Model:

  • Subjects: Female Lewis rats ($n=18$).
  • Groups: Anti-MuSK group ($n=12$, immunized with N-terminal MuSK60 peptide + CFA + Pertussis Toxin) vs. Sham group ($n=6$, CFA + PT only).
  • Phenotyping: Rats were monitored for disease score (0–4) and body weight. Only rats reaching a disease score of 2 were included.
  • Endpoints: Animals were euthanized either upon reaching humane endpoints (severe weight loss) or after 10 days of stable disease score 2.

• Tissue Sampling:

  • Muscles Analyzed: Soleus (slow-twitch dominant), Diaphragm (mixed respiratory), Sternohyoideus (neck, fast-twitch dominant), EDL, Tibialis Anterior (TA), and Gastrocnemius.
  • Sample Types: Snap-frozen for proteomics; cryo-embedded for immunohistochemistry (IHC).

• Experimental Techniques:

  • Serology: Radioimmunoprecipitation assay (RIPA) to quantify MuSK antibody titers.
  • Immunohistochemistry (IHC):
    • NMJ Morphology: Staining for pre-synaptic nerves (NF-M, SV2) and post-synaptic AChRs ($\alpha$-bungarotoxin) to assess fragmentation and denervation.
    • Fiber Morphology: Staining for Laminin (fiber borders) and Myosin Heavy Chain I (MHC-I/Type I) to measure fiber cross-sectional area and minimum Feret diameter.
  • Proteomics (LC-MS/MS):
    • Workflow: Filter-Aided Sample Preparation (FASP) followed by TMT-16plex labeling.
    • Instrumentation: NanoLC coupled to Q Exactive HF-X Orbitrap.
    • Analysis: Quantitative proteomics using Proteome Discoverer and DEqMS for differential expression. Gene Set Enrichment Analysis (GSEA) performed using MSigDB (GO, Reactome, WikiPathways) and MitoCarta 3.0 for mitochondrial profiling.

3. Key Results

A. Disease Phenotype and NMJ Integrity

• Seropositivity: All Anti-MuSK rats developed high titers of anti-MuSK antibodies; Sham rats were seronegative.
• Systemic Effects: Anti-MuSK rats exhibited significant body weight loss (~12.5%) compared to weight-gaining Sham rats.
• NMJ Pathology: Confocal microscopy of gastrocnemius revealed:
  • Significant reduction in AChR area.
  • Increased NMJ fragmentation.
  • High rates of denervation (9%) and partial innervation (38%) in Anti-MuSK rats vs. fully innervated Sham muscles.

B. Muscle Atrophy and Fiber-Type Selectivity

• Whole Muscle Weight: The soleus muscle showed a ~32% reduction in wet weight in Anti-MuSK rats. In contrast, fast-twitch muscles (EDL, Gastrocnemius) showed no absolute weight loss; when normalized to body weight, they were actually heavier in the disease group.
• Fiber Morphology:
  • Soleus: Marked atrophy of the entire muscle (mean fiber diameter reduced from 43.5 $\mu$m to 33.0 $\mu$m).
  • Mixed Muscles (EDL, TA, Sternohyoideus): No change in overall fiber diameter, but Type I (slow-twitch) fibers showed significant atrophy. Type II fibers remained unaffected.
  • Conclusion: Atrophy is strictly fiber-type selective, targeting slow-twitch fibers regardless of the muscle's overall composition.

C. Proteomic Remodeling

• Differential Expression: The proteome of the soleus was most severely affected (621 upregulated, 540 downregulated proteins), followed by the diaphragm, with the sternohyoideus showing the least changes.
• Key Upregulated Proteins (All Muscles): NCAM1 and MUSTN1 were consistently upregulated across all muscle types, suggesting a generalized myocellular stress response to MuSK dysfunction.
• Gene Set Enrichment Analysis (GSEA):
  • Soleus (Downregulated): Significant depletion of mitochondrial (ETC complexes I-V, Cytochrome C), ribosomal (40S and 60S subunits), and myosin complex proteins.
  • Diaphragm: Showed a mixed phenotype. While mitochondrial proteins were partially downregulated, there was a compensatory upregulation of ribosomal and proteasomal (ubiquitin-proteasome system) proteins, suggesting an attempt to maintain proteostasis.
  • Sternohyoideus: Minimal proteomic changes, consistent with its lack of gross atrophy.
• Correlation with Mass Loss: In the soleus, muscle mass loss strongly correlated (negative correlation) with increased abundance of ubiquitin-proteasome components (e.g., UBE2N, NEDD4) and calcium-handling proteins (e.g., CASQ1), implicating proteolytic and bioenergetic stress.

4. Significance and Conclusions

• Mechanism of Atrophy: The study demonstrates that MuSK-MG atrophy is not merely a result of disuse (denervation) but involves intrinsic myocellular signaling defects. The specific targeting of slow-twitch fibers suggests MuSK plays a direct role in the maintenance of slow-fiber mass, potentially via non-canonical pathways like BMP/TGF-β signaling.
• Proteomic Signature: The study provides the first comprehensive proteomic map of MuSK-MG muscle, revealing a "myopathy-like" state characterized by:
  1. Mitochondrial dysfunction: Loss of ETC components and mitochondrial ribosomes.
  2. Translational suppression: Downregulation of ribosomal machinery in atrophic muscles.
  3. Proteolytic activation: Upregulation of ubiquitin-proteasome pathways.
• Therapeutic Implications: The findings highlight that treating MuSK-MG may require strategies beyond restoring NMJ transmission. Therapies targeting mitochondrial biogenesis, protein synthesis, or specific fiber-type preservation (particularly slow-twitch) could be beneficial.
• Biomarkers: The consistent upregulation of NCAM1 and MUSTN1 across all muscle types identifies them as potential systemic biomarkers for MuSK-MG disease activity.

In summary, this paper establishes that MuSK autoimmunity triggers a profound, fiber-type-specific myopathy involving mitochondrial collapse and translational failure, distinct from the purely synaptic defects seen in other forms of MG.